Cytokinetics (CYTK) Change in Cash (2016 - 2024)
Historic Change in Cash for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $48.0 million.
- Cytokinetics' Change in Cash rose 25980.35% to $48.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$18.2 million, marking a year-over-year decrease of 13930.8%. This contributed to the annual value of -$18.2 million for FY2024, which is 13930.8% down from last year.
- Cytokinetics' Change in Cash amounted to $48.0 million in Q4 2024, which was up 25980.35% from -$143.3 million recorded in Q3 2024.
- Cytokinetics' Change in Cash's 5-year high stood at $139.7 million during Q3 2020, with a 5-year trough of -$143.3 million in Q3 2024.
- Moreover, its 5-year median value for Change in Cash was $12.0 million (2020), whereas its average is $2.9 million.
- Over the last 5 years, Cytokinetics' Change in Cash had its largest YoY gain of 254892.85% in 2020, and its largest YoY loss of 358094.35% in 2020.
- Over the past 5 years, Cytokinetics' Change in Cash (Quarter) stood at -$117.8 million in 2020, then surged by 118.76% to $22.1 million in 2021, then tumbled by 276.69% to -$39.1 million in 2022, then surged by 134.14% to $13.3 million in 2023, then soared by 259.8% to $48.0 million in 2024.
- Its Change in Cash stands at $48.0 million for Q4 2024, versus -$143.3 million for Q3 2024 and $70.2 million for Q2 2024.